MXCT - MaxCyte, Inc.
NEXT EARNINGS:
Mar 10, 2026
(in 13 days)
EPS Est: $-0.08
|
Rev Est: $9.2M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.00
DETAILS
HIGH:
$6.00
LOW:
$6.00
MEDIAN:
$6.00
CONSENSUS:
$6.00
UPSIDE:
659.49%
Market Cap:
84.27M
Volume:
1,079,588
Avg Volume:
1,166,023
52 Week Range:
0.643-3.97
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.30
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
114
IPO Date:
2021-07-30
EPS (TTM):
-0.39
P/E Ratio:
-10.62
Revenue (TTM):
38.63M
Total Assets:
239.47M
Total Debt:
18.03M
Cash & Equiv:
27.88M
Rev Growth (5Y):
12.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-22.9%
Debt/Equity:
0.09
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-0.12 | $-0.11 | -9.1% | $6.8M | $9.4M | -27.4% |
| 2025-08-06 | $-0.12 | $-0.10 | -20.0% | $8.5M | $10.4M | -17.9% |
| 2025-05-07 | $-0.10 | $-0.10 | 0.0% | $10.4M | $9.6M | +8.6% |
| 2025-03-11 | $-0.10 | $-0.12 | +16.7% | $8.7M | $9.3M | -6.2% |
| 2024-11-06 | $-0.11 | $-0.13 | +15.4% | $8.2M | $7.7M | +6.5% |
| 2024-08-06 | $-0.09 | $-0.14 | +35.7% | $10.4M | $7.4M | +41.5% |
| 2024-05-07 | $-0.09 | $-0.14 | +35.7% | $11.3M | $7.5M | +52.0% |
| 2024-03-12 | $-0.05 | $-0.10 | +50.0% | $15.7M | $13.1M | +19.7% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38.63M | 41.29M | 44.26M | 33.89M | 26.17M | 21.62M | 16.67M | 13.98M | 12.27M | 9.29M | 7.16M | 6.80M |
| Net Income | (41.05M) | (37.92M) | (23.57M) | (19.08M) | (11.82M) | (12.89M) | (8.87M) | (9.92M) | (3.35M) | (1.45M) | (1.84M) | (958,200) |
| EPS | -0.39 | -0.37 | -0.19 | -0.22 | -0.18 | -0.24 | -0.17 | -0.20 | -0.10 | -0.03 | -1.59 | -0.02 |
| Total Assets | 239.47M | 268.27M | 286.65M | 284.12M | 51.78M | 29.99M | 24.27M | 31.40M | 16.07M | 6.40M | 6.30M | 2.50M |
| Total Debt | 18.03M | 18.74M | 16.09M | 5.68M | 6.97M | 7.21M | 5.06M | 5.03M | 5.01M | 5.04M | 4.91M | 1.86M |
| Cash & Equivalents | 27.88M | 46.51M | 11.06M | 47.78M | 18.76M | 15.21M | 11.25M | 25.34M | 11.73M | 2.41M | 3.41M | 764,900 |
| Operating Cash Flow | (27.61M) | (21.69M) | (14.78M) | (10.68M) | (8.78M) | (8.80M) | (10.49M) | (9.68M) | (2.33M) | (180,500) | (1.93M) | (557,800) |
| Free Cash Flow | (29.26M) | (25.39M) | (33.26M) | (14.51M) | (10.85M) | (10.07M) | (11.20M) | (10.29M) | (2.55M) | (275,000) | (2.07M) | (607,300) |
| FCF per Share | -0.28 | -0.25 | -0.33 | -0.16 | -0.16 | -0.18 | -0.22 | -0.21 | -0.08 | -0.01 | -1.80 | -0.01 |
| Book Value | 206.25M | 232.17M | 253.97M | 262.90M | 33.23M | 13.60M | 12.28M | 19.60M | 5.08M | (3.08M) | (1.65M) | (1.54M) |
| Cash & ST Investments | 154.48M | 168.29M | 227.34M | 255.04M | 34.76M | 16.71M | 14.44M | 25.34M | 11.73M | 2.41M | 3.41M | 764,900 |
| ROC Equity | -0.20 | -0.16 | -0.09 | -0.07 | -0.36 | -0.95 | -0.72 | -0.51 | -0.66 | N/A | N/A | N/A |